NO994757L - Method for Oral Administration of Proteins - Google Patents

Method for Oral Administration of Proteins

Info

Publication number
NO994757L
NO994757L NO994757A NO994757A NO994757L NO 994757 L NO994757 L NO 994757L NO 994757 A NO994757 A NO 994757A NO 994757 A NO994757 A NO 994757A NO 994757 L NO994757 L NO 994757L
Authority
NO
Norway
Prior art keywords
proteins
oral administration
oral
administration
Prior art date
Application number
NO994757A
Other languages
Norwegian (no)
Other versions
NO994757D0 (en
Inventor
Nicholas A Peppas
Anthony M Lowman
Tsuneji Nagai
Mariko Morishita
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of NO994757D0 publication Critical patent/NO994757D0/en
Publication of NO994757L publication Critical patent/NO994757L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
NO994757A 1997-04-02 1999-09-30 Method for Oral Administration of Proteins NO994757L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4228097P 1997-04-02 1997-04-02
US6136797P 1997-10-08 1997-10-08
PCT/US1998/006563 WO1998043615A1 (en) 1997-04-02 1998-04-02 Method for oral delivery of proteins

Publications (2)

Publication Number Publication Date
NO994757D0 NO994757D0 (en) 1999-09-30
NO994757L true NO994757L (en) 1999-11-29

Family

ID=26719055

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994757A NO994757L (en) 1997-04-02 1999-09-30 Method for Oral Administration of Proteins

Country Status (14)

Country Link
EP (1) EP0975328A1 (en)
JP (1) JP2002512607A (en)
KR (1) KR20010005952A (en)
CN (1) CN1259045A (en)
AU (1) AU727053B2 (en)
BR (1) BR9808466A (en)
CA (1) CA2285457A1 (en)
IL (1) IL132176A0 (en)
NO (1) NO994757L (en)
NZ (1) NZ500075A (en)
PL (1) PL335974A1 (en)
TR (1) TR199903240T2 (en)
WO (1) WO1998043615A1 (en)
YU (1) YU49699A (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
DE10040592A1 (en) * 2000-08-15 2002-03-07 Aventis Res & Tech Gmbh & Co Composition for oral administration of drugs, e.g. peptidomimetics or sparingly soluble antibiotics, containing hydrogel copolymer of unsaturated acid and polyalkylene glycol ester as resorption improver
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
GB0206048D0 (en) * 2002-03-14 2002-04-24 Croda Int Plc Use
EP1494732B1 (en) 2002-03-20 2008-01-30 MannKind Corporation Inhalation apparatus
DK1786784T3 (en) 2004-08-20 2011-02-14 Mannkind Corp Catalysis of diketopiperazine synthesis
CN104436170B (en) 2004-08-23 2018-02-23 曼金德公司 Diketopiperazine salt for drug delivery
US8110212B2 (en) 2005-04-07 2012-02-07 Drexel University Bioactive thermogelling polymer systems and methods of their use
DK1916995T4 (en) 2005-07-29 2022-10-03 Stichting Groningen Centre For Drug Res PH-CONTROLLED, PULSABLE DELIVERY SYSTEM, METHODS OF MANUFACTURE AND USE THEREOF
ES2439455T3 (en) * 2005-08-01 2014-01-23 Mannkind Corporation Procedure of preserving the function of insulin producing cells
AU2006290227B2 (en) 2005-09-14 2012-08-02 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
KR20080096809A (en) 2006-02-22 2008-11-03 맨카인드 코포레이션 Method for Improving Pharmaceutical Properties of Microparticles Containing Diketopiperazine and Active Agents
CA2655026C (en) 2006-06-15 2016-08-02 Microvention, Inc. Embolization device constructed from expansible polymer
WO2009086208A2 (en) 2007-12-21 2009-07-09 Microvention, Inc. Hydrogel filaments for biomedical uses
SG10201507036TA (en) 2008-06-13 2015-10-29 Mannkind Corp A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI614024B (en) 2008-08-11 2018-02-11 曼凱公司 Ultra-fast use of insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
MX2011009512A (en) 2009-03-11 2011-11-29 Mannkind Corp Apparatus, system and method for measuring resistance of an inhaler.
US10639396B2 (en) 2015-06-11 2020-05-05 Microvention, Inc. Polymers
BRPI1014645B1 (en) 2009-04-30 2020-07-07 Technip France method and system for sharing mooring lines
MY157166A (en) 2009-06-12 2016-05-13 Mankind Corp Diketopiperazine microparticles with defined specific surface areas
HUP0900482A2 (en) 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
AU2010298026B2 (en) 2009-09-24 2015-11-05 Microvention, Inc. Injectable hydrogel filaments for biomedical uses
AU2010313530B2 (en) 2009-10-26 2015-12-17 Microvention, Inc. Embolization device constructed from expansile polymer
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp Dry powder inhaler and composition therefor
EP2694402B1 (en) 2011-04-01 2017-03-22 MannKind Corporation Blister package for pharmaceutical cartridges
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
HK1200318A1 (en) 2011-10-24 2015-08-07 曼金德公司 Methods and compositions for treating pain
WO2013158781A1 (en) 2012-04-18 2013-10-24 Microvention, Inc. Embolic devices
EP2872205B1 (en) 2012-07-12 2017-02-08 MannKind Corporation Dry powder drug delivery systems
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
WO2014144895A1 (en) 2013-03-15 2014-09-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
KR102465025B1 (en) 2013-07-18 2022-11-09 맨카인드 코포레이션 Heat-stable dry powder pharmaceutical compositions and methods
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
WO2015021044A1 (en) * 2013-08-05 2015-02-12 University Of Rochester Compositions and methods for stimuli-responsive release of a therapeutic agent
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10124090B2 (en) 2014-04-03 2018-11-13 Terumo Corporation Embolic devices
WO2015167752A1 (en) 2014-04-29 2015-11-05 Microvention, Inc. Polymers including active agents
WO2015167751A1 (en) 2014-04-29 2015-11-05 Microvention, Inc. Polymers
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10265405B2 (en) 2014-11-18 2019-04-23 Board Of Regents, The University Of Texas System Polymers for delivery of factor VIII and/or factor IX
WO2024130101A1 (en) * 2022-12-16 2024-06-20 Wake Forest University Health Sciences Hydrogel compositions and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976576A (en) * 1956-04-24 1961-03-28 Wichterle Otto Process for producing shaped articles from three-dimensional hydrophilic high polymers
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
ES335314A1 (en) * 1966-01-06 1967-12-01 Ceskoslovenska Akademie Ved Improvements introduced in the preparation of insoluble vehicles of substances at least partially soluble, biologically active. (Machine-translation by Google Translate, not legally binding)
US3607848A (en) * 1967-08-07 1971-09-21 Ceskoslovenska Akademie Ved Method for preparing insoluble,cross-linked organic hydrogels comprising copolymers of glycol monoesters with diesters
US3885078A (en) * 1968-03-06 1975-05-20 Ceskoslovenska Akademie Ved Hydrogel laminates and method of manufacturing thereof
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
FR2601026B1 (en) * 1986-04-15 1988-09-16 Rhone Poulenc Chimie DRY MATERIAL MOISTURIZABLE IN AN AQUEOUS GEL CONTAINING PARTICLES OF DISPERSE POLYMERS, METHOD FOR ITS PREPARATION AND ITS APPLICATION IN BIOLOGY

Also Published As

Publication number Publication date
CN1259045A (en) 2000-07-05
BR9808466A (en) 2001-08-07
EP0975328A1 (en) 2000-02-02
JP2002512607A (en) 2002-04-23
IL132176A0 (en) 2001-03-19
KR20010005952A (en) 2001-01-15
AU727053B2 (en) 2000-11-30
TR199903240T2 (en) 2000-05-22
NO994757D0 (en) 1999-09-30
YU49699A (en) 2002-12-10
WO1998043615A1 (en) 1998-10-08
PL335974A1 (en) 2000-06-05
CA2285457A1 (en) 1998-10-08
NZ500075A (en) 2001-03-30
AU6880998A (en) 1998-10-22

Similar Documents

Publication Publication Date Title
NO994757D0 (en) Procedure for Oral Administration of Proteins
IS5245A (en) Pharmaceutical preparation of omeprazole
NO995134D0 (en) Improved Methods for Preparation of Activated Protein C
NO986202L (en) Method of Preparation of Recombinant Adunovirus
DE69615887D1 (en) Oral pharmaceutical preparation containing olanzapine
FI973733L (en) Pharmaceutical preparation and method for its preparation
NO951630L (en) Method of administration of azithromycin
EE04277B1 (en) Method for the preparation of derivatives of the taxoid class
DK0754061T3 (en) New oral pharmaceutical dosage form
FI963679L (en) Stabilized composition for oral administration of peptides
EE200100259A (en) Pharmaceutical preparation of moxifloxacin
KR970000228A (en) Oral preparations of S-etodolak
NO995251D0 (en) Procedure for administering halotherapy
NO986177D0 (en) Method of Preparation of Therapeutic DNA
EE04154B1 (en) Method of preparation of omeprazole
DK0868911T3 (en) Rapamycin preparations for oral administration
FI973229L (en) New pharmaceutical composition
FI974578L (en) Method of administration of levosimendan
NO994049D0 (en) Method of Preparing Pharmaceutical Compounds
EE9900404A (en) Method for the preparation of arylaminotriazolopyridines
NO943480L (en) Procedure for direct fitting of dentures
FI974235A0 (en) New methods of administration
KR970000226A (en) Oral Formulations of S-Ibuprofen
KR970701559A (en) STABILIZED COMPOSITION FOR ORAL ADMINISTRATION OF PEPTIDES
UA25519A (en) METHOD OF ICHTRACAROTIDE MEDICINAL MEDICINAL PRODUCTS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application